Literature DB >> 20707786

Use of the Ambu(®) aScope™ in 10 patients with predicted difficult intubation.

E Pujol1, A M López, R Valero.   

Abstract

Fibreoptic intubation is the gold standard for patients with predicted difficult intubation. The Ambu(®) aScope™ is a single-use device for fibreoptic tracheal intubation. We assessed its performance in 10 patients with predicted difficult tracheal intubation. The procedure was easy and successful in nine patients. However, the limited time of use did not permit intubation in one patient who required three attempts with different size tracheal tubes. The limited image resolution that can be expected of a single-use fibreoptic system and the absence of a suction channel are other potential limitations. On the other hand, being single-use this device has the advantage of avoiding the risk of infectious disease transmission and is always ready to use.
© 2010 The Authors. Journal compilation © 2010 The Association of Anaesthetists of Great Britain and Ireland.

Entities:  

Mesh:

Year:  2010        PMID: 20707786     DOI: 10.1111/j.1365-2044.2010.06477.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  4 in total

1.  Use of Ambu aScope for tracheal intubation in anticipated difficult airway, a boon.

Authors:  Mathews Jacob; D Vivekanand; Anoop Sharma
Journal:  Med J Armed Forces India       Date:  2015-04-15

Review 2.  Advances in Laryngoscopy.

Authors:  Michael Aziz
Journal:  F1000Res       Date:  2015-12-08

3.  Cost analysis of single-use (Ambu® aScope™) and reusable bronchoscopes in the ICU.

Authors:  S Perbet; M Blanquet; C Mourgues; J Delmas; S Bertran; B Longère; V Boïko-Alaux; P Chennell; J-E Bazin; J-M Constantin
Journal:  Ann Intensive Care       Date:  2017-01-03       Impact factor: 6.925

4.  Single use and conventional bronchoscopes for Broncho alveolar lavage (BAL) in research: a comparative study (NCT 02515591).

Authors:  Seher Raza Zaidi; Andrea M Collins; Elena Mitsi; Jesús Reiné; Kayleigh Davies; Angela D Wright; Jessica Owugha; Richard Fitzgerald; Amitava Ganguli; Stephen B Gordon; Daniela Mulari Ferreira; Jamie Rylance
Journal:  BMC Pulm Med       Date:  2017-05-05       Impact factor: 3.317

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.